- Home
- FORA vs TNYA Comparison
FORA vs TNYA Comparison
Compare FORA & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORA
- TNYA
- Stock Information
- Founded
- FORA 2014
- TNYA 2016
- Country
- FORA United States
- TNYA United States
- Employees
- FORA N/A
- TNYA N/A
- Industry
- FORA Computer Software: Prepackaged Software
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- FORA Technology
- TNYA Health Care
- Exchange
- FORA Nasdaq
- TNYA Nasdaq
- Market Cap
- FORA 62.7M
- TNYA 74.5M
- IPO Year
- FORA N/A
- TNYA 2021
- Fundamental
- Price
- FORA $1.99
- TNYA $0.41
- Analyst Decision
- FORA Strong Buy
- TNYA Strong Buy
- Analyst Count
- FORA 1
- TNYA 6
- Target Price
- FORA $5.00
- TNYA $8.60
- AVG Volume (30 Days)
- FORA 27.4K
- TNYA 1.8M
- Earning Date
- FORA 05-16-2025
- TNYA 05-07-2025
- Dividend Yield
- FORA N/A
- TNYA N/A
- EPS Growth
- FORA N/A
- TNYA N/A
- EPS
- FORA N/A
- TNYA N/A
- Revenue
- FORA $20,153,263.00
- TNYA N/A
- Revenue This Year
- FORA $13.31
- TNYA N/A
- Revenue Next Year
- FORA N/A
- TNYA N/A
- P/E Ratio
- FORA N/A
- TNYA N/A
- Revenue Growth
- FORA N/A
- TNYA N/A
- 52 Week Low
- FORA $1.85
- TNYA $0.39
- 52 Week High
- FORA $4.03
- TNYA $4.78
- Technical
- Relative Strength Index (RSI)
- FORA 49.09
- TNYA 36.35
- Support Level
- FORA $1.93
- TNYA $0.42
- Resistance Level
- FORA $2.11
- TNYA $0.53
- Average True Range (ATR)
- FORA 0.12
- TNYA 0.04
- MACD
- FORA 0.00
- TNYA 0.01
- Stochastic Oscillator
- FORA 34.75
- TNYA 6.90
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.